Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Potential therapeutic targets in the NF-kappaB pathway for Alzheimer's disease.

Collister KA, Albensi BC.

Drug News Perspect. 2005 Dec;18(10):623-9. Review.

PMID:
16491164
2.

The nuclear factor-kappaB (NF-kappaB): from a versatile transcription factor to a ubiquitous therapeutic target.

Yates LL, Górecki DC.

Acta Biochim Pol. 2006;53(4):651-62. Epub 2006 Oct 27. Review.

3.

NF-kappaB as a potential molecular target for cancer therapy.

Lee CH, Jeon YT, Kim SH, Song YS.

Biofactors. 2007;29(1):19-35. Review.

PMID:
17611291
4.

NF-kappa B as a therapeutic target in autoimmune disease.

O'Sullivan B, Thompson A, Thomas R.

Expert Opin Ther Targets. 2007 Feb;11(2):111-22. Review.

PMID:
17227228
5.

Transcription factor NF-kappaB: friend or foe of neurons?

Lezoualc'h F, Behl C.

Mol Psychiatry. 1998 Jan;3(1):15-20. Review.

PMID:
9491808
6.

Targeting the CREB pathway for memory enhancers.

Tully T, Bourtchouladze R, Scott R, Tallman J.

Nat Rev Drug Discov. 2003 Apr;2(4):267-77. Review.

PMID:
12669026
7.

NF-kappa B as a target for cancer therapy.

Melisi D, Chiao PJ.

Expert Opin Ther Targets. 2007 Feb;11(2):133-44. Review.

PMID:
17227230
8.

Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.

Wong ET, Tergaonkar V.

Clin Sci (Lond). 2009 Mar;116(6):451-65. doi: 10.1042/CS20080502. Review.

PMID:
19200055
9.

NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach.

Egan LJ, Toruner M.

Ann N Y Acad Sci. 2006 Aug;1072:114-22. Review.

PMID:
17057194
10.

Inflammation and NF-kappaB in Alzheimer's disease and diabetes.

Granic I, Dolga AM, Nijholt IM, van Dijk G, Eisel UL.

J Alzheimers Dis. 2009;16(4):809-21. doi: 10.3233/JAD-2009-0976. Review.

PMID:
19387114
11.

Dynamic protein complexes regulate NF-kappaB signaling.

Wegener E, Krappmann D.

Handb Exp Pharmacol. 2008;(186):237-59. doi: 10.1007/978-3-540-72843-6_10. Review.

PMID:
18491055
12.

Regulating the regulator: NF-kappaB signaling in heart.

Hall G, Hasday JD, Rogers TB.

J Mol Cell Cardiol. 2006 Oct;41(4):580-91. Epub 2006 Sep 1. Review.

PMID:
16949095
13.
14.

NF-kappaB functions in the nervous system: from development to disease.

Mémet S.

Biochem Pharmacol. 2006 Oct 30;72(9):1180-95. Epub 2006 Sep 12. Review.

PMID:
16997282
16.

Transcription factor cross-talk: the estrogen receptor and NF-kappaB.

Kalaitzidis D, Gilmore TD.

Trends Endocrinol Metab. 2005 Mar;16(2):46-52. Review.

PMID:
15734144
17.

Inhibitors of NF-kappaB signaling: 785 and counting.

Gilmore TD, Herscovitch M.

Oncogene. 2006 Oct 30;25(51):6887-99. Review.

PMID:
17072334
18.

Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms.

Pizzi M, Spano P.

Eur J Pharmacol. 2006 Sep 1;545(1):22-8. Epub 2006 Jun 16. Review.

PMID:
16854410
19.

Marine natural products as targeted modulators of the transcription factor NF-kappaB.

Folmer F, Jaspars M, Dicato M, Diederich M.

Biochem Pharmacol. 2008 Feb 1;75(3):603-17. Epub 2007 Aug 7. Review.

PMID:
17919455
20.

The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis.

Brown KD, Claudio E, Siebenlist U.

Arthritis Res Ther. 2008;10(4):212. doi: 10.1186/ar2457. Epub 2008 Aug 21. Review.

Supplemental Content

Support Center